Loading...

Expect a future valuation of 22x as AstraZeneca bets on pipeline strength

Published
04 Feb 25
Updated
30 Apr 25
Unike's Fair Value
SEK 1,673.42
8.5% undervalued intrinsic discount
30 Apr
SEK 1,531.50
Loading
1Y
-13.6%
7D
-0.9%

Author's Valuation

SEK 1.7k

8.5% undervalued intrinsic discount

Unike's Fair Value

Shared on30 Apr 25
Fair value Decreased 35%

Unike has decreased revenue growth from 9.9% to 8.0%.

Shared on08 Mar 25
Fair value Increased 0.50%

Unike has increased profit margin from 25.0% to 28.0%.

Shared on05 Feb 25

Unike made no meaningful changes to valuation assumptions.